ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
247.66
+2.62 (1.07%)
At close: May 12, 2025, 4:00 PM
247.66
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$503,159
Profits / Employee
$131,589
Market Cap
36.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9,980 | -160 | -1.58% |
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | 7,770 | 530 | 7.32% |
Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
Jun 30, 2018 | 5,940 | -140 | -2.30% |
Jun 30, 2017 | 6,080 | 830 | 15.81% |
Jun 30, 2016 | 5,250 | 910 | 20.97% |
Jun 30, 2015 | 4,340 | 240 | 5.85% |
Jun 30, 2014 | 4,100 | 200 | 5.13% |
Jun 30, 2013 | 3,900 | 200 | 5.41% |
Jun 30, 2012 | 3,700 | 250 | 7.25% |
Jun 30, 2011 | 3,450 | 250 | 7.81% |
Jun 30, 2010 | 3,200 | 300 | 10.34% |
Jun 30, 2009 | 2,900 | 200 | 7.41% |
Jun 30, 2008 | 2,700 | 0 | - |
Jun 30, 2007 | 2,700 | 200 | 8.00% |
Jun 30, 2006 | 2,500 | 573 | 29.74% |
Jun 30, 2005 | 1,927 | 407 | 26.78% |
Jun 30, 2004 | 1,520 | 56 | 3.83% |
Jun 30, 2003 | 1,464 | 214 | 17.12% |
Jun 30, 2002 | 1,250 | 297 | 31.16% |
Jun 30, 2001 | 953 | 348 | 57.52% |
Jun 30, 2000 | 605 | 104 | 20.76% |
Jun 30, 1999 | 501 | 111 | 28.46% |
Jun 30, 1998 | 390 | 106 | 37.32% |
Jun 30, 1997 | 284 | 55 | 24.02% |
Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RMD News
- 10 days ago - Top 15 High-Growth Dividend Stocks To Consider For May 2025 - Seeking Alpha
- 11 days ago - Resmed Acquires VirtuOx - GlobeNewsWire
- 18 days ago - ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast - Benzinga
- 18 days ago - ResMed: Cornering The Market In Sleep Solutions - Seeking Alpha
- 19 days ago - ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - ResMed slightly beats quarterly profit estimates on sleep devices demand - Reuters
- 19 days ago - Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025 - GlobeNewsWire
- 21 days ago - Resmed Names Salli Schwartz as Chief Investor Relations Officer - GlobeNewsWire